TITLE:
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human Prostate
AUTHORS:
Manabu Kamiyama, Mizuya Fukasawa, Yoshio Takihana, Norifumi Sawada, Hiroshi Nakagomi, Mitsuharu Yoshiyama, Isao Araki, Masayuki Takeda
KEYWORDS:
Prostate Cancer; Prostate Cell; Cannabinoid Receptor; CB1
JOURNAL NAME:
Open Journal of Urology,
Vol.3 No.2,
May
17,
2013
ABSTRACT:
Background: Cannabinoid receptor subtype 1
(CB1) has a relationship to the proliferation of various cells including
malignant tumoral cells. We investigated and compared the expression of CB1 in benign and malignant human prostate
tissues and in benign and malignant human prostate cell lines, as well as its
function for the proliferation of human prostate cancer cells. Methods: Real-time quantitative PCR was performed to compare its expressions in human
prostate tissues (normal, benign hyperplasia, and cancer) and prostate cell lines
(3 normal and 3 malignant). For localization of CB1, immunofluorescent staining with rabbit anti-CB1 polyclonal
antibodies and tetramethyl isothiocyanate (TRITC)-labeled swine anti-rabbit
immunoglobulin (DAKO) were used under fluorescence microscope. To
further analyze whether cell death was induced by anandamide (non-selective
agonist for CB1/CB2) via a receptor dependent mechanism, the viability of DU145 cells,
which is known as androgen-insensitive prostate cancer cell, was measured using
MTT assay. Results: CB1mRNA was found to be expressed in the all 3
human prostate tissues, however, CB1 protein was expressed in BPH and low grade
malignant PC tissues, but not in high grade malignant PC tissues. CB1 as for
cell lines, the expression of CB1 was low in malignant cell lines except for DU145.
Anandamide elicited cell death, which was significantly inhibited by AM251
(selective antagonist for CB1), indicating that cell death induced by anandamide in DU145 cells was mediated by CB1. Anandamide time-dependently elicits up-regulation of CB1 in DU145 cells. Conclusions: CB1
may be an inhibitory regulator of androgen-insensitive human prostate cancer
epithelial cell growth.